More news: Health / Surgery
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Next-generation Diagnostics Paving the Way to Reach Personalized Medicine According to Frost & Sullivan - Precision diagnostics will deliver personalized medicine to engage patients, says Frost & Sullivan
Next-generation Diagnostics Paving the Way to Reach Personalized Medicine According to Frost & Sullivan

 

PRZOOM - /newswire/ - San Antonio, TX, United States, 2022/06/14 - Precision diagnostics will deliver personalized medicine to engage patients, says Frost & Sullivan.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

New technologies, sequencing methods, novel software algorithms, and multi-omic approaches empower patients to take more active control of their health outcomes and offers them personalized medicine. The forces of change and partnerships are building the foundation to better engage with patients and approach new demands, according to Frost & Sullivan’s recent analysis, Next-generation Diagnostics Outlook 2022. The market has a promising future outlook, and its revenue is expected to grow from $99.23 billion in 2021 to $138.34 billion by 2026 at a CAGR of 6.9%.

Digital health solutions facilitate a dramatic shift in care delivery from traditional to alternative sites, simplifying the accessibility of diagnostic tests, which results in an automated testing experience for laboratories to ensure rapid scalability. Patients have greater access control and faster turnaround times to results, and providers can triage patients quickly through an efficient and connected workflow.

“Automation, machine learning, and deep learning are pivoting biology toward a data-informed scientific discipline. As a result, service digitization is a hot topic in laboratories and among device manufacturers,” noted Amartya Bose, Industry Analyst at Frost & Sullivan. “Accelerated approval pathways will continue to motivate the rapid development of next-generation diagnostics that will focus on connecting tests to enhance the quality of care. Robust companion diagnostics will foster personalized medicine, converging pharma and diagnostics, lowering the costs, and transforming drug development.”

Bose added: “Early detection to initiate optimal treatment plans is a paradigm shift in personalized care. The structural shifts driven by alternate care sites provide opportunities to improve accessibility and design innovative care delivery solutions with considerations for personalizing consumer-oriented diagnostic testing.”

As the market’s business model evolves, industry participants can find tangible growth opportunities by offering:

• Liquid biopsy as a biomarker-driven tool for precision oncology: Liquid biopsy developers are encouraged to design and demonstrate clinical validity in prospective cohort studies. Biomarker performance and clinical validity studies will ensure private payor market access.

• Decentralized and point-of-care molecular testing for infectious disease: Test developers should demonstrate evidence via clinical studies to bring laboratory-quality testing to the retail pharmacy setting. The model will inspire the creation of a new care delivery paradigm that will connect diagnostic tests and create innovative delivery models.

• Smart labs as a service for the digital transformation of diagnostic laboratories: As value additions and subscription-based business models continue to evolve, original equipment manufacturers should connect directly with laboratories. Growth is expected across all technology pillars that support the smart lab ecosystem, with significant opportunities around robotics and automation, the internet of things and artificial intelligence.

Next-generation Diagnostics Outlook, 2022 is the latest addition to Frost & Sullivan’s Transformational Health research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Next-generation Diagnostics Outlook, 2022 / K73A-55

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Next-generation Diagnostics Paving the Way to Reach Personalized Medicine According to Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: María Celeste Bailo - Frost.com 
877-463-7678 celeste.bailo[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Health / Surgery Most Recent Related Press Releases:

AGS Health, A Global Leader in Revenue Cycle Management Solutions Establishes Operations in Jaipur, India
InterSystems Partners with the Rhodes Group to Improve Hepatitis C Treatment in New Mexico
BostonGene Announces 0 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
Roche Diagnostics India Earns the Frost & Sullivan 2021 India Competitive Strategy Leadership Award
Wolters Kluwer Lauded by Frost & Sullivan for Enabling Aligned Decision-making with its Clinical Decision Support Solutions
Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns Finds Frost & Sullivan
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025 Finds Frost & Sullivan
Innovative MedTech Business Models Will Enable Cost-effective, Decentralized and Patient-centric Care Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Heavenly Culture World Peace Restoration

Visit  BizJobs.com

Visit  RightITnow, Inc.







 
  ©2022 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today